The Albanese-Collins AI Biosecurity Office enters Day 12 today, while the U.S. federal silence on the NYT/Stanford Relman-lab pathogen-assembly transcripts crosses Day 9 — and Australia's open BICON synthetic-nucleic-acid screening letter remains the only state-capacity instrument moving on the record. [1] The paper's Thursday brief at Day 11 / Day 8 framed the asymmetry as "Canberra ships an office while Washington runs the clock"; Day 12 hardens it.

The BICON letter, signed by Australians for AI Safety, asks the Director of Biosecurity to use existing Biosecurity Act 2015 powers to require that imported synthetic nucleic acids be sourced from providers that screen orders against sequences of concern — a measure the letter says can be "introduced without new legislation, new agencies, or a lengthy review process." [2] Members of the International Gene Synthesis Consortium, including Twist Bioscience, IDT, and GenScript, already screen voluntarily; the letter targets the gap, not the norm. [2]

Australia is governing on Day 12 with statutes the United States also has — the 2024 OSTP nucleic-acid screening framework is on file at HHS, and the October 13, 2026 screening-window step-down is already in U.S. federal regulations. Washington's Day 9 silence is the divergence; the BICON letter is the receipt; the state-capacity anchor holds.

-- ANNA WEBER, Berlin